Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Matthew Baker

Orthopaedic Surgery Festus, MO Medical Doctor

NPI 1386888527 CMS profile 1391505

1400 US Highway 61, Festus, MO 63028

Open in the dashboard

General payments

$31,010

246 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Matthew Baker of Festus, MO is reported in the CMS Open Payments database as having received $31,010 across 246 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 85th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,765 19
2024 General $5,137 39
2023 General $1,276 16
2022 General $4,497 35
2021 General $2,739 36
2020 General $5,392 39
2019 General $10,204 62

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Matthew Baker
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Matthew Baker were reported at $1,765. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Matthew Baker Orthopaedic Surgery median Middle half National median
2019 $10,204 $644 $140–$2,844 $163
2020 $5,392 $312 $75–$1,860 $114
2021 $2,739 $520 $117–$2,495 $132
2022 $4,497 $598 $128–$2,731 $149
2023 $1,276 $461 $128–$2,264 $160
2024 $5,137 $497 $134–$2,475 $164
2025 $1,765 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Stryker Corporation $8,351 103 payments
  2. Elite Orthopedics, LLC $6,921 28 payments
  3. Arthrex, Inc. $4,836 24 payments
  4. Smith+Nephew, Inc. $4,340 47 payments
  5. FX Shoulder USA, Inc $3,917 7 payments
  6. Integra LifeSciences Corporation $785 7 payments
  7. TriMed, Inc. $527 6 payments
  8. Zimmer Biomet Holdings, Inc. $326 5 payments
  9. DePuy Synthes Sales Inc. $325 6 payments
  10. Tenex Health Inc. $189 2 payments
  11. Other $493 11 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $12,138 213 payments
  2. Travel and Lodging $10,177 23 payments
  3. Education $8,445 9 payments
  4. Consulting Fee $250 1 payment
Products named General payments · program years 2019–2025
  1. REUNION Trauma & Extremeties $3,418 34 payments
  2. Bioinductive Implant with Arthroscopic Delivery System - Medium $2,348 22 payments
  3. REUNION Trauma & Extremeties $1,492 21 payments
  4. Mini-Open Latarjet $1,201 8 payments
  5. ENDOBUTTON $1,201 8 payments
  6. AEQUALIS PERFORM REVERSED $879 12 payments
  7. VARIAX $763 10 payments
  8. FREEDOM WRIST $703 6 payments
  9. EXTERNAL FIXATION SYSTEM $703 6 payments
  10. GAMMA $650 8 payments
  11. Other $8,375 117 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 5 drugs

Part D claims

339

Median for Orthopedic Surgery: 203

Drug cost

$3,611

Median for Orthopedic Surgery: $1,433

Branded share of claims

58.7%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 148 $1,801
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 51 $823
Oxycodone Hcl Generic 86 $704
Methylprednisolone Generic 24 $186
Tramadol Hcl Generic 30 $96

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 77 billing codes

Paid by Medicare

$121,780

Of which drugs: $939

Medicare patients

316

Average age 73

Services billed

1,278

190 women, 126 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Diabetes 35%
Depression 33%
Ischemic heart disease 25%
COPD 24%
Atrial fibrillation 23%
Osteoporosis 20%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg J0702 Office 47 264 $939

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

246 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Missouri

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record